The largest database of trusted experimental protocols

17 protocols using geneart service

1

Generation of Chimeric IL-15 Construct

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amplified genes (IL-15 and IgHg2a) were separately cloned into PCR2.1 TOPO Vector (Thermo Fisher Scientific). K322A mutations into IgG2 Fc and N72D mutation into IL-15 were introduced by site-directed mutagenesis (Agilent). IL-2 signal peptide (SP) was inserted in pcDNA3.1 vector downstream of CMV promoter by using GeneArt Service, Thermo Fisher Scientific, USA. Sequentially IL-15 CDS and IgHg2 genes were inserted in the IL-2-pcDNA3.1 vector to make IL-2SP-N72DIL-15CDS-K322AIgHg2-pcDNA3.1 construct (chimeric IL-15). All cloning, mutagenesis, and fusion constructs were confirmed by Sanger sequencing.
+ Open protocol
+ Expand
2

Plasmid Constructs for Poliovirus, Coxsackievirus, and Rhinovirus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid pXpA-SH coding for the full-length poliovirus type I (strain Mahoney) cDNA with introduced SalI and HpaI restriction sites in the 5’ and 3’ non-translated regions was described in [41 (link)], and its derivative plasmid pXpA-RenR coding for a poliovirus replicon with Renilla luciferase gene substituting the capsid coding region was described in [42 (link)]. To introduce the BFA-resistant mutations in 2C and 3A either PCR fragments synthesized using isolated RNA of BFA-resistant viruses as a template, or gene fragments synthesized by GeneArt service (Thermo Fisher) were introduced into pXpA-SH and pXpA-RenR using standard cloning techniques. All mutations were verified by sequencing. Plasmids p53CB3T7 and pACYC-RV1A coding for the cDNA of Coxsackievirus B3 (strain Nancy) and rhinovirus 1A (strain ATCC VR-1559) under the control of T7 promotor were kindly provided by Professor Frank van Kuppeveld (University of Utrecht, the Netherlands) and Dr. Margaret Scull (University of Maryland), respectively. Expression plasmids pM1-2Cs coding for 2Cs of poliovirus (wt and BFA-resistant), were constructed using pM1-MT vector for a high level of mammalian expression (Roche Biosciences). Cloning details are available upon request. Plasmids coding for human Arf1, 3, 4, 5, and 6 fused to EGFP were a gift from Dr. Catherine Jackson (Université Paris Diderot, France).
+ Open protocol
+ Expand
3

Constructing IVT Templates with Poly(A) Tails

Check if the same lab product or an alternative is used in the 5 most similar protocols
All vectors and their RNA transcripts are shown in Figure 1A and 1B. A series of vectors for the IVT was modified from pGEM-T Easy (Promega, Madison, WI). In brief, a cassette of 5′UTR of β-globin and multiple cloning sites (MCS) was synthesized by GeneArt service (Thermo Fisher Scientific) and cloned into the AatII/SpeI restriction sites of pGEM-T Easy. A single or double fragment of β-globin 3′UTR was inserted downstream of the MCS to generate 5′-MCS-1β and 5′-MCS-2β constructs respectively. AatII/BamHI restriction followed by blunt-end ligation was performed to generate MCS-1β and MCS-2β. eGFP flanked by BamHI restriction sites was cloned into the MCS of each constructs. Human ETV2 transcript variant 1(NM_014209.3) and GATA2 isoform 1 (NM_001145661.1) were cloned into 5′-MCS-1β construct to generate IVT template for ETV2. To generate IVT templates with 120-A tract, a reverse primer containing 120 T base pairs and forward primer were used in a PCR reaction (primers are listed in Supplemental Table 1). All the PCR reactions were carried out using Phusion (Thermo Fisher Scientific), 30 cycles of 95°C for 10 seconds; 52°C for ETV2; 58°C for GATA2 for 10 seconds; 72°C for 50 seconds. PCR products were run on the agarose gel and extracted using QIAEX II gel extraction kit (Qiagen, Valencia, CA) before further processing.
+ Open protocol
+ Expand
4

Generation of Spliceosomal snRNA Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mutants of U2 (U2weakNSS, U2noNSS and U2stNSS) were created by site-directed mutagenesis using specific primers listed in Supplementary Data 3 and confirmed by sequencing. The U2-MS2 RNA construct, which includes the promoter sequence, was described previously30 (link). The U2weakNSS-MS2 construct was prepared by site-directed mutagenesis using specific primers listed in Supplementary Data 3. U1-1 (GRCh38/hg38:chr1:16,840,617–16,840,779), U1-26P (GRCh38/hg38:chr14:35,025,383–35,025,595), U4-1 (GRCh38/hg38:chr12:120,730,865–120,731,040), and U5F-1 (GRCh38/hg38:chr1:44,721,744–44,721,901) pre-snRNAs were designed and synthesized by GeneArt service (Thermo Fisher Scientific) including variants containing mutations strengthening (stNSS) and relaxing NSS (noNSS).
+ Open protocol
+ Expand
5

Producing Wild-type Gsα Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression and purification of Gsα, Gβγ, and mini-Gsα have been described previously (Huang et al., 2021 (link)) with the only difference being that a wild-type Gsα was used in the current work. To generate this construct, a double-stranded DNA fragment for the wild-type Gsα short isoform was codon optimized and synthesized using the GeneArt service from Thermofisher. This fragment carried overlapping sequences with the previously described pET15b MBP-Gsα mutant sequence (Huang et al., 2021 (link)). The plasmid was digested with XhoI and SacI (New England BioLabs, Ipswich, MA, USA) to remove the mutant Gsα sequence and purified via electrophoresis and gel extraction kit (Bio Basic, Markham, Canada). The resulted plasmid backbone and DNA fragment were fused using the pEasy assembly kit from TransGen Biotech following manufacturer’s instructions. The plasmid was transformed into Escherichia coli (E. coli) BL21 (DE3) cells and a resulting colony containing the gene for the wild-type Gsα was selected for protein expression.
+ Open protocol
+ Expand
6

Predicting and Validating miR-181 Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
miR‐181 targets were predicted using TargetScan v.6.2 (http://www.targetscan.org/, release June 2012) and miRWalk (http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/) using mouse and human searches and broadly conserved microRNA target sites settings. 3′UTR regions with wild‐type or mutated miR‐181a target site were synthesized using GeneArt service (Thermo Scientific) and cloned into a GFP TOPO vector (Thermo Scientific). Sequences cloned are listed in Table S3. C2C12 myoblasts were cultured in 96‐well plates and transfected using Lipofectamine 2000™ (Thermo Scientific) with WT or mutant sensor (200 ng), with 100 nM miR scrambled or miR‐181a mimic (100 nM, GE Healthcare; Soriano‐Arroquia, House, et al., 2016). Each experiment was carried out using at least two independent plasmid preparations in triplicates. GFP fluorescence was measured 48 hr following transfections using FLUOstar Optima microplate reader (BMG Labtech).
+ Open protocol
+ Expand
7

In vitro mRNA Production and Protein Tagging

Check if the same lab product or an alternative is used in the 5 most similar protocols
mRNA for transfection of exogenous proteins was produced in vitro from the T7 promoter-containing pGEM vector using the mMESSAGE mMACHINE T7 Transcription Kit (Thermo Fisher Scientific) as per the manufacturer's instructions. Genes encoding proteins of interest were directly synthesized as gene strings using the GeneArt service (ThermoFisher) and ligated into pGEM following digestion with AgeI and HindIII. For HaloTag-fused constructs these were followed by a short sequence encoding a GSGSG flexible linker and then the HaloTag gene at the 3′ terminus. For GNAi2-SNAP-tag, the SNAP-tag gene was inserted between nucleotides 342 and 343, corresponding to residues A114 and E115 in the αB-αC loop of Gαi2, following a short GSG linker. This tagging site has been demonstrated previously to retain Gαi2 activity (van Unen et al., 2016 (link)).
+ Open protocol
+ Expand
8

Constructing Plasmid Vectors for Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
gBlocks gene fragments for the respective target sites or miRNAs (table S3) with the restriction site(s) at their ends were purchased from IDT. Restriction site cloning was performed using the standard method. Full length ORC4 expression plasmid was generated using gene synthesis using a full length human ORC4 and cloned into CAG-IRES-GFP vector using the GeneArt service (Thermo Fisher).
+ Open protocol
+ Expand
9

Constructing Plasmid Vectors for Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
gBlocks gene fragments for the respective target sites or miRNAs (table S3) with the restriction site(s) at their ends were purchased from IDT. Restriction site cloning was performed using the standard method. Full length ORC4 expression plasmid was generated using gene synthesis using a full length human ORC4 and cloned into CAG-IRES-GFP vector using the GeneArt service (Thermo Fisher).
+ Open protocol
+ Expand
10

Prdx6-202 transcript miR-24-3p regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
5ʹUTR of Prdx6-202 transcript regions with either the wild-type or mutated miR-24-3p target sites were synthesized using GeneArt service (Thermo Scientific). The wild type or mutated sequences were subcloned into a GFP TOPO vector (Thermo Scientific). C2C12 myoblasts were cultured in 96-well plates and transfected using Lipofectamine 2000™ (Thermo Scientific) with either 200ng of the wild type or mutant sensor and with either 100nM of the miR scrambled control or 100nM miR-24 mimic.
Each experiment was carried out using at least two independent plasmid preparations in triplicate.
GFP fluorescence was measured 48 hr following transfections using FLUOstar Optima microplate reader (BMG Labtech).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!